The Transformative Development and Progress of the PCCTC
Dr Charles Ryan is joined by the leadership of the Prostate Cancer Clinical Trials Consortium, a group that has developed innumerable trials and therapies for advanced prostate cancer.
CellCentric Signs Agreement with the PCCTC for Phase II Clinical Trial Expansion Into the US
CellCentric has signed an agreement with the PCCTC to help select and manage US sites for the ongoing evaluation of CCS1477.